Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Revenue (2025)

RenovoRx (RNXT) has disclosed Revenue for 1 consecutive years, with $238000.0 as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to $238000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.1 million for FY2025, 2511.63% up from the prior year.
  • Revenue hit $238000.0 in Q4 2025 for RenovoRx, down from $266000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $422000.0 in Q2 2025 to a low of $197000.0 in Q1 2025.